SANUWAVE Health, Inc.

Equities

SNWV

US80303D1072

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets 03:44:07 2024-05-01 pm EDT 5-day change 1st Jan Change
0.02 USD +11.11% Intraday chart for SANUWAVE Health, Inc. -9.09% +53.85%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Sanuwave Health, Inc. Provides Earnings Guidance for the First Quarter 2024 CI
SANUWAVE Health, Inc. Appoints Peter Sorensen as CFO CI
Transcript : SANUWAVE Health, Inc., Q4 2023 Earnings Call, Mar 22, 2024
SANUWAVE Health, Inc. Provides Revenue Guidance for the First Quarter and Full Year of Fiscal Year Ending December 31, 2024 CI
SANUWAVE Health, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Declaration of Voting Results by SANUWAVE Health CI
Transcript : SANUWAVE Health, Inc. - Shareholder/Analyst Call
SANUWAVE Health, Inc. announced that it has received $4.6 million in funding CI
Manchester Management Engages in Discussions with SANUWAVE Health CI
SANUWAVE Health, Inc. Provides Revenue Guidance for the Fourth Quarter and Fiscal Year of 2023 CI
SANUWAVE Health, Inc. announced that it has received $1.8 million in funding CI
Transcript : SANUWAVE Health, Inc., Q3 2023 Earnings Call, Nov 10, 2023
SANUWAVE Health, Inc. Provides Revenue Guidance for the Fourth Quarter of 2023 CI
Earnings Flash (SNWV) SANUWAVE HEALTH Reports Q3 Revenue $5M MT
SANUWAVE Health, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Sanuwave Health, Inc. Provides Revenue Guidance for Third Quarter Ending September 30, 2023 CI
SEP Acquisition, Sanuwave Health Strike Merger Agreement MT
SANUWAVE Health, Inc. entered into a definitive merger agreement to acquire SEP Acquisition Corp. from Mercury Sponsor Group I LLC, investors affiliated with Sweat Equity Partners, LP, Mercury Life Sciences and others. CI
Transcript : SANUWAVE Health, Inc., Q2 2023 Earnings Call, Aug 11, 2023
Earnings Flash (SNWV) SANUWAVE HEALTH Posts Q2 Revenue $4.7M MT
SANUWAVE Health, Inc. Provides Revenue Guidance for the Third Quarter of 2023 CI
SANUWAVE Health, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Sanuwave Signs Distribution Agreement with Pacific Medical, Inc CI
SANUWAVE Health, Inc. Appoints Andrew Walko as President CI
Manchester Management Engages in Discussions with SANUWAVE Health CI
Chart SANUWAVE Health, Inc.
More charts
Sanuwave Health, Inc. is an ultrasound and shock wave technology company. The Company is a provider of Food and Drug Administration (FDA)-approved wound care products. It is focused on the research, development, and commercialization of its patented, non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. The Company applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, aesthetic/cosmetic, and others. Its two primary systems are UltraMIST and PACE. The UltraMIST system provides, through a fluid mist, low-frequency, non-contact, and pain free ultrasound energy deep inside the wound bed that promotes healing from within. The PACE systems use acoustic pressure shockwaves generated by the Company's Pulsed Acoustic Cellular Expression (PACE) technology to converge at precise selected targets to produce an extremely short duration compression burst.
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. SNWV Stock
  4. News SANUWAVE Health, Inc.
  5. Earnings Flash (SNWV) SANUWAVE HEALTH Reports Q3 Revenue $5M